Elizabeth O. Ofili, M.D., M.P.H., F.A.C.C., is a professor of medicine at Morehouse School of Medicine and a practicing cardiologist with Morehouse Healthcare in Atlanta, Georgia. She serves as chief medical officer of the Morehouse Choice Accountable Care Organization, a Centers for Medicare & Medicaid Services (CMS) Shared Savings Program, which includes both Morehouse Healthcare and Federally Qualified Health Centers across the state of Georgia.
Dr. Ofili is a nationally and internationally recognized clinician scientist with particular focus on cardiovascular disparities and women’s health. She has been continuously funded by NIH since 1994, with a track record in clinical trials that affect health disparities. In 2002, as president of the Association of Black Cardiologists (ABC), Dr. Ofili led the initiative to implement the landmark African-American Heart Failure Trial (A-HeFT), whose findings changed practice guidelines for the treatment of heart failure in African Americans. Dr. Ofili also established the ABC Center for Women’s Health and Epidemiology and currently leads the ABC Cardiovascular Implementation Study (CVIS), a practice-based research registry that is integrating social determinants of health and technology innovation to support clinical trials and address health disparities at the point of care.
Dr. Ofili brings All of Us her knowledge of health and medicine to technology and innovation. She is the founder and chief scientific officer of AccuHealth Technologies, which is “empowering patient-centered care through technology and health coaching.” AccuHealth Technologies holds the patent for “a system and method for chronic illness care” and has developed the Health 360x platform to support population health and clinical trials.
Dr. Ofili helped raise more than $175 million to fund pioneering research and training infrastructure at Morehouse School of Medicine. She leads multi-institutional regional and national networks funded by NIH to address diversity and inclusion in the biomedical workforce, as well as community engagement to ensure participation of underrepresented populations in NIH, foundations, and industry-sponsored research. She serves as a principal investigator (PI) of the Georgia Clinical and Translational Science Alliance (GaCTSA), the statewide initiative involving Emory University, Morehouse School of Medicine, the Georgia Institute of Technology, the University of Georgia, and partnering health systems and research organizations. As contact PI of the Research Centers in Minority Institutions (RCMI) Coordinating Center, she works with 18 to 22 National Institute on Minority Health and Health Disparities (NIMHD)–funded RCMI across 14 states and territories to support investigator development, dissemination, and metrics for data standards and evaluation across the consortium.
Dr. Ofili has received more than 50 national awards, including one for the “Changing the Face of Medicine: The Rise of America’s Women Physicians” exhibit at the National Library of Medicine. She is an elected member of the National Academies of Science, Engineering, and Medicine,. Dr. Ofili currently serves as membership chair of medicine and subspecialties in dermatology and pathology, the largest member section at the National Academy of Medicine.
